Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Dalton Transactions (Cambridge, England : 2003)|February 18, 2015
Deferitazole, a new orally active iron chelatorRobert C Hider, Xiaole Kong, Vincenzo Abbate, et al.
Bioorganic & Medicinal Chemistry Letters|August 4, 2009
Discovery of a novel azepine series of potent and selective 5-HT2C agonists as potential treatments for urinary incontinencePaul E Brennan, Gavin A Whitlock, Danny K H Ho, et al.
Bioorganic & Medicinal Chemistry Letters|November 5, 2008
Novel 2-imidazoles as potent, selective and CNS penetrant alpha1A adrenoceptor partial agonistsLee R Roberts, Justin Bryans, Kelly Conlon, et al.
Bioorganic & Medicinal Chemistry Letters|April 11, 2008
Novel 2-imidazoles as potent and selective alpha1A adrenoceptor partial agonistsGavin A Whitlock, Kelly Conlon, Gordon McMurray, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 29, 2017
Nonclinical Cardiovascular Studies of Prucalopride, a Highly Selective 5-Hydroxytryptamine 4 Receptor AgonistKelly Conlon, Joris H De Maeyer, Chris Bruce, et al.
Bioorganic & Medicinal Chemistry Letters|November 5, 2020
A highly potent maytansinoid analogue and its use as a cytotoxic therapeutic agent in gold nanoparticles for the treatment of hepatocellular carcinomaJohn Porter, Yao Ding, Sarah J M Hale, et al.
Bioconjugate Chemistry|December 25, 2018
DM1 Loaded Ultrasmall Gold Nanoparticles Display Significant Efficacy and Improved Tolerability in Murine Models of Hepatocellular CarcinomaSarah J M Hale, Richard D Perrins, Cristina Espinosa Garcı A, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 16, 2014
Inhibition of TRPM8 channels reduces pain in the cold pressor test in humansWendy J Winchester, Katrina Gore, Sophie Glatt, et al.
Pageof 2